Applied Pharmaceutical Analysis 2018

October 1-3, 2018

Short Courses September 30th

Sheraton Boston Hotel 
39 Dalton Street 
Boston, MA 02199

 

APA 2018 Conference Program

 

APA 2018 Plenary Speakers

donna dambach     

Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech

Translation Insights in Nonclinical Safety Assessment

     
    

Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development, BMS

The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization

     
Richard Smith APA2018     

Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory

New Developments in Ion Mobility-Mass Spectrometry Enabling Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

     
Joe Cornicelli  

Joseph Cornicelli, PhD, Senior Director In Vivo Pharmacology, Charles River Laboratories

Research Models for Non-Alcoholic Steatohepatitis: The Need and Challenges for Evaluating Candidate Therapies

 

APA 2018 Confirmed Speakers

Jonathan Bauman APA2018

Johnathan Bauman, Principal Scientist, Pfizer

Accelerating the Delivery of Small Molecule High Resolution Accurate Mass Structure Elucidation Results Through the Use of Thermo Scientific™ Compound Discoverer Software™

 

Joseph Camardo, Senior Vice President Celgene Global Health and Global Medical Affairs, Celgene

Attention to Neglected Tropical Diseases: The Impact of the Pharmaceutical Industry and the Mission of Celgene Global Health

         
Andrea Casasola LaMacchia APA2018

Andrea Casasola-LaMacchia, Postdoctoral Scientist, Pfizer

Quantitative Biomarkers & Biomeasures BioMedicine Design

  Joe Cornicelli

Joseph Cornicelli, Senior Director, In Vivo Pharmacology, Charles River Laboratories

Research Models for NASH

         
 Arindam Dasgupta  

Arindam Dasgupta, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA

Common BA/BE Inspection Observations and their Mitigation Strategies

   Bill APA photo  

William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego

Antiparasitic Drug Discovery from Marine Cyanobacteria

         
Jochem Gokemeijer

Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb

Title TBA

  Sylvia2

Sylvia Janetzki, Founder and President, ZellNet Consulting

Monitoring the Function of Single Immune Cells - How to Tackle this Daunting Task and Apply Cutting-Edge Developments for Obtaining Meaningful Data

         
Vibha Jawa

Vibha, Jawa, Director Biologics and Vaccine Development, Merck

Current Perspectives on Preclinical Predictive Tools for Immunogenicity Risk Assessment and their Clinical Translation

   Sadik Kassim  

 

Sadik Kassim, CSO, Mustang Bio

CART-ography:  Lessons Learned from the Analytical Characterization of the First Two FDA Approved Chimeric Antigen Receptor Therapies

 

         
Kochansky Christopher pict APA2018

Christopher Kochansky, Research Scientist, Merck

Automated Metabolite Identification for Design Ideation

   Ashutosh Kulkarni APA2018

Ashutosh Kulkarni, Director of Clinical Pharmacology, Nonclinical and Translational Sciences Group, Allergan

ADME Screening Paradigm for Covalent Inhibitor Drugs – Role of Traditional vs Non-Traditional Assays

         
Xiaomin Liang APA2018

Xiaomin Liang, Research Scientist, Drug Metabolism, Gilead

Use of In Vitro Tools and Genetic Data to Identify Transporter Endogenous Biomarkers

   John O Link

John O. Link, Vice President, Medicinal Chemistry, Gilead Sciences 

Drug Discovery in "Rulebreaker" Chemical Space: Ledipasvir and Velpatasvir

         
Holly Maw

Holly Maw, Scientist IV, Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals

N-methylation of BI 187004 by thiol-S-methyltransferase

   Jun Qu  

Jun Qu, Professor, Department of Pharmaceutical Sciences, SUNY-Buffalo, Chief Scientist in Bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences

Sensitive and Robust Trapping-Micro-LC-MS for the Quantification of Biomarkers and Antibody Therapeutics

         
Giovanna Scapin APA2018

Giovanna Scapin, Principal Scientist, Merck

Insights into the Insulin Receptor Activation: the Cryo-EM Structure of the IR in Complex with Insulin

   Keith Sutton Pict APA2018  

Keith Sutton, Senior Research Scientist, Charles River Laboratories, UK

When the Cell is the Drug, Challenges for Bioanalysis

         
 S Voytek sq  

Sarah Voytek, Associate Director, Preclinical Development, bluebird bio

Drug Distribution Analysis in the Preclinical Development of Gene and Cell Therapy Products

   Debra Luffer Atlas APA2018
 

Debra Luffer-Atlas, Senior Research Fellow, Eli Lilly

An ADME Perspective on DILI Hazard Identification  

         
Jing Tao

Jing-Tao Wu, Vice President DMPK and Investigative Toxicology, Alnylam Pharmaceuticals

Mechanistic ADME of siRNA-GaINAc Conjugates

  Yuhong Xiang APA2018  

Yuhong Xiang, Scientist, Pfizer

Development of a Robust Neutralizing Antibody (NAb) Assay with High Drug and Target Tolerance to Support Clinical Development of an anti-TFPI Therapeutic Monoclonal Antibody (mAb)

         
Ming Yao picture APA2018

Ming Yao, Senior Research Scientist, Bristol-Myers Squibb

Fast and Comprehensive Detection and Characterization of Cyclic Peptide Metabolites using Software-Aided Data Processing Tools

     

 

         

 

Other confirmed speakers:

Michael F. Skelly, Ph.D., Lead Pharmacologist, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Study Integrity and Surveillance, U.S. Food and Drug Administration

Jianwei Shen, Ph.D., Prinicipal Scientist, AbbVie 

Chuck Gu, Ph.D. Prinicipal Scientist, Biotransformation Group Lead, Biogen

Guowen Liu, Ph.D., Director of Bioanalyis, Agios

 

 

Proposed Sessions for APA 2018 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Challenges of Immunotherapy in a Regulated Environment

Bioanalytical Support for Novel Therapies

Miscellaneous Topics in Bioanalysis

New Technologies and Applications

Discovery Bioanalysis and New Technologies

Anti-Drug Antibodies (ADA)

Information Technology - Knowledge Management

New Technologies

Omics

Mechanistic ADME

Unusual Metabolites

Toxicity/Safety

Speciality Molecules: Going Beyond the Rule of 5

Software for Met ID

Combined Mechanistic Adme and Discovery Bioanalysis

Role of DMPK in New Modalities

Exploratory Biomarker Analysis

Beyond ADME and Bioanalysis

NASH

CNS

Global Health

Rare/Neglected Diseases

Novel Drug Delivery Systems

   

 

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2018 conference online.

APA 2018 will take place October 1-3, 2018 at:

Sheraton Boston Hotel

Boston, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy